Tesio F, De Baz H, Panarello G, Calianno G, Quaia P, Raimondi A, Schinella D
Servizio di Nefrologia e Dialisi, Civil Hospital, Pordenone, Italy.
Artif Organs. 1994 Apr;18(4):301-4. doi: 10.1111/j.1525-1594.1994.tb02200.x.
Central vascular catheters are used to access the central vascular system in both acute and chronic uremic patients undergoing hemodialysis. Among different approaches, the internal jugular vein seems to have less adverse effects. We describe our long-term experience with a two-catheter system. Percutaneous jugular vein cannulation was performed using Medcomp silicone rubber catheters. The study included 108 patients undergoing hemodialysis. One- and 2-year survival was 93 and 91%, respectively; 36 died because of unrelated causes. Blood flow rate was 284 mL/min; venous pressure at 1 year was 90 mm Hg. Complications included accidental withdrawal (6), dysfunction (4), catheter clotting (11), mediastinal hematoma (2), pneumothorax (1), and sepsis (7). Good long-term survival and a low complication rate make this system a safe and reliable method of access for long-term hemodialysis.
中心血管导管用于急性和慢性尿毒症血液透析患者的中心血管系统通路建立。在不同的置管途径中,颈内静脉似乎不良反应较少。我们描述了我们使用双导管系统的长期经验。采用Medcomp硅橡胶导管经皮进行颈静脉置管。该研究纳入了108例血液透析患者。1年和2年生存率分别为93%和91%;36例因无关原因死亡。血流量为284 mL/分钟;1年时静脉压为90 mmHg。并发症包括意外拔管(6例)、功能障碍(4例)、导管凝血(11例)、纵隔血肿(2例)、气胸(1例)和败血症(7例)。良好的长期生存率和低并发症发生率使该系统成为长期血液透析安全可靠的通路建立方法。